Role of Oxidative Stress and the Identification of Biomarkers Associated With Thyroid Dysfunction in Schizophrenics

Background: Schizophrenia is associated with a deficiency of dietary antioxidants like vitamin B6, B9, and B12 resulting in defective methylation leading to hyperhomocysteinemia. Hyperhomocysteinemia causes mitochondrial DNA damage, oxidative stress, vascular damage, and lipid peroxidation. Oxidative stress and increase in reactive oxygen species result in 8-oxodG production which induces apoptosis of both astrocytes and thyrocytes thus predisposing them to thyroid dysfunction and neurodegeneration. Furthermore, the presence of excessive free radicals increases thyroid thermogenesis causing hyperthyroidism or its excess may cause hypothyroidism by inhibiting iodide uptake. In the present study, we evaluated the various biomarkers associated with thyroid dysfunction in schizophrenics. Materials and Methods: 288 patients suffering from schizophrenia and 100 control subjects were screened for liver function tests (LFTs) such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and total bilirubin (TB). Also, the stress markers, namely malondialdehyde (MDA), homocysteine, cysteine, methionine, the thyroid profile including triiodothyronine (T3), thyroxine (T4), thyroid-stimulating hormone (TSH), thyroxine peroxide antibody (TPO-Ab); TSH receptor-Ab (TSHr-Ab), dietary antioxidants, lipids, cytokines, aminoacids and hormones, vitamins and trace elements, and other biochemical parameters. Results: The LFTs showed elevated levels of ALT (45.57 +/- 4.87 Vs. 26.41 +/- 3.76 U/L), AST (40.55 +/- 1.34 Vs. 21.92 +/- 3.65 U/L), ALP (121.54 +/- 4.87 Vs. 83.76 +/- 5.87 U/L), and total bilirubin (2.63 +/- 0.987 Vs. 1.10 +/- 0.056 mg/dl), in schizophrenics than controls. Increased levels of MDA (3.71 +/- 0.967 Vs. 1.68 +/- 0.099) and homocysteine (17.56 +/- 2.612 Vs. 6.96 +/- 1.987 mu mol/L were observed in schizophrenics compared to the controls, indicating increased stress. Levels of cysteine and methionine were decreased in schizophrenics than the controls (1.08 +/- 0.089 Vs. 4.87 +/- .924 mu mol/L and 17.87 +/- 1.23 Vs. 99.20 +/- 5.36 mu mol/L). The levels of TPO-Ab (IU/ml), Tg-Ab (pmol/L), and TSHr-Ab (IU/L) were observed to be higher in the patients' group as compared to control subjects (9.84 +/- 2.56 Vs. 5.81 +/- 1.98, 55.50 +/- 2.98 Vs. 32.95 +/- 2.87 and 2.95 +/- 0.0045 Vs. 1.44 +/- 0.0023 respectively). Levels of Vitamin B6, B9, and B12 were also significantly decreased in the patients compared to the healthy controls. Conclusion: The schizophrenics, demonstrated altered liver function, increased stress markers, and decreased dietary antioxidants. Reduced primary and secondary antioxidant levels, may result in hyperhomocysteinemia and cause further DNA and mitochondrial damage. Therefore, homocysteine and/or prolactin levels may serve as candidate prognostic markers for schizophrenia. Also, both neurological symptoms and the susceptibility to thyroid disorders may be prevented in the initial stages of this debilitating disorder by appropriate dietary supplementation of antioxidants which can rectify a reduction in primary and secondary antioxidants, and disturbed prolactin-serotonin-dopamine interactions in schizophrenics.

Automated summary

Schizophrenia is associated with deficiencies in dietary antioxidants which can result in hyperhomocysteinemia and further DNA and mitochondrial damage. The study found that schizophrenics show altered liver function, increased stress markers, and decreased dietary antioxidants. Dietary supplementation of antioxidants may prevent neurological symptoms and susceptibility to thyroid disorders in the early stages of schizophrenia.